secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiromic Biopharma, Inc. (—)
CIK:        0001792581
Form:       8-K
Filed at:   2023-07-18T23:59:59+00:00
Accession:  0001558370-23-011954
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiromic BioPharma amends bylaws to set stockholder meeting quorum at one-third of outstanding shares
--------------------------------------------------------------------------------

- Quorum reduced to 33.33% of issued and outstanding shares entitled to vote.
- Amendment approved by Board on July 17, 2023 and effective immediately.
- Change intended to improve the Company's ability to hold stockholder meetings.
- No other changes to Bylaws were made.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792581/000155837023011954/0001558370-23-011954-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792581/000155837023011954/krbp-20230717x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-011954

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer